| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |